NURS 5434 FAMILY III FNP CAD AND LIPIDS
EXAM BANK QUESTIONS WITH RATIONALES
UTA LATEST VERIFIED
This high-yield, verified assessment bank contains 50
comprehensive multiple-choice questions with answers
and detailed rationales tailored directly for Advanced
Practice Nursing lipid and CAD modules. It covers critical
clinical guidelines, pharmacology classes, and diagnostic
criteria necessary to master complex family nurse
practitioner exams. Designed specifically for rapid
retention, this resource serves as the ultimate study guide
to secure an A grade on advanced cardiology
assessments.
1. A 55-year-old African American male presents for a
routine wellness exam. His history is remarkable only
for mild osteoarthritis. According to epidemiological
data discussed in the Family III curriculum, which
ethnic group has the highest overall mortality rate
from coronary heart disease (CHD)?
A) Non-Hispanic Whites
B) Hispanic Americans
C) Asian Americans
D) African Americans
Answer: D) African Americans
Rationale: Epidemiological data consistently
,demonstrate that African Americans experience
higher mortality rates from coronary heart disease
and stroke compared to other ethnic groups, driven
by a higher prevalence of severe hypertension,
metabolic syndrome, and systemic healthcare
disparities.
2. A 62-year-old patient with stable angina undergoes
an exercise stress test. At what minimum percentage
of arterial lumen obstruction do standard cardiac
stress tests typically begin to reliably detect
ischemia?
A) 30% to 40%
B) 50% to 60%
C) 70% to 75%
D) 90% to 95%
Answer: C) 70% to 75%
Rationale: Standard non-invasive exercise stress
testing typically requires at least a 70% to 75%
epicardial coronary artery obstruction to compromise
myocardial perfusion enough to cause detectable ST-
segment changes or clinical angina during exertion.
3. An FNP student is explaining the primary benefit of
HMG-CoA reductase inhibitors (statins) to a patient
with a 12% 10-year ASCVD risk score. Beyond
lowering serum LDL-C, how do statins structurally
stabilize vulnerable atherosclerotic plaques?
A) By thinning the fibrous cap to allow fluid clearance
B) By hardening plaques and calcifying the core to prevent
,rupture
C) By increasing the lipid core volume to absorb
inflammatory cells
D) By dissolving the calcified layers of the arterial wall
Answer: B) By hardening plaques and calcifying the core
to prevent rupture
Rationale: Statins possess pleiotropic effects that
decrease vascular inflammation, reduce the lipid core
size, and increase the thickness and calcification
(hardening) of the fibrous cap, which directly lowers
the risk of plaque rupture and acute myocardial
infarction.
4. When evaluating a comprehensive fasting lipid
panel for a primary prevention patient, which lipid
fraction is directly implicated as the primary
atherogenic vehicle and serves as the primary target
for therapy?
A) High-Density Lipoprotein Cholesterol (HDL-C)
B) Low-Density Lipoprotein Cholesterol (LDL-C)
C) Chylomicrons
D) Very Low-Density Lipoprotein (VLDL)
Answer: B) Low-Density Lipoprotein Cholesterol (LDL-C)
Rationale: LDL-C particles penetrate the damaged
endothelial lining of arteries, undergo oxidation, and
trigger the inflammatory cascade that forms foam
cells and eventual atheromas, making LDL-C the
primary target of lipid-lowering guidelines.
, 5. A 45-year-old female with a history of clinical
ASCVD requires high-intensity statin therapy.
According to the current ACC/AHA guidelines, what is
the expected percentage reduction in serum LDL-C
when a high-intensity statin is used correctly?
A) 15% to <30%
B) 30% to <50%
C) ≥50%
D) <15%
Answer: C) ≥50%
Rationale: High-intensity statin therapy is strictly
defined by its ability to lower baseline serum LDL-C
levels by 50% or greater when taken consistently as
prescribed.
6. Which of the following statin regimens represents a
validated high-intensity lipid-lowering option?
A) Pravastatin 40 mg daily
B) Simvastatin 40 mg daily
C) Atorvastatin 20 mg daily
D) Rosuvastatin 20 mg daily
Answer: D) Rosuvastatin 20 mg daily
Rationale: Only Rosuvastatin 20–40 mg and
Atorvastatin 40–80 mg are clinically classified as high-
intensity statin therapies. Simvastatin 40 mg and
Atorvastatin 20 mg are moderate-intensity.
7. A 52-year-old male with type 2 diabetes mellitus and
an LDL-C of 115 mg/dL is being evaluated. He has no
prior history of ASCVD. According to primary
EXAM BANK QUESTIONS WITH RATIONALES
UTA LATEST VERIFIED
This high-yield, verified assessment bank contains 50
comprehensive multiple-choice questions with answers
and detailed rationales tailored directly for Advanced
Practice Nursing lipid and CAD modules. It covers critical
clinical guidelines, pharmacology classes, and diagnostic
criteria necessary to master complex family nurse
practitioner exams. Designed specifically for rapid
retention, this resource serves as the ultimate study guide
to secure an A grade on advanced cardiology
assessments.
1. A 55-year-old African American male presents for a
routine wellness exam. His history is remarkable only
for mild osteoarthritis. According to epidemiological
data discussed in the Family III curriculum, which
ethnic group has the highest overall mortality rate
from coronary heart disease (CHD)?
A) Non-Hispanic Whites
B) Hispanic Americans
C) Asian Americans
D) African Americans
Answer: D) African Americans
Rationale: Epidemiological data consistently
,demonstrate that African Americans experience
higher mortality rates from coronary heart disease
and stroke compared to other ethnic groups, driven
by a higher prevalence of severe hypertension,
metabolic syndrome, and systemic healthcare
disparities.
2. A 62-year-old patient with stable angina undergoes
an exercise stress test. At what minimum percentage
of arterial lumen obstruction do standard cardiac
stress tests typically begin to reliably detect
ischemia?
A) 30% to 40%
B) 50% to 60%
C) 70% to 75%
D) 90% to 95%
Answer: C) 70% to 75%
Rationale: Standard non-invasive exercise stress
testing typically requires at least a 70% to 75%
epicardial coronary artery obstruction to compromise
myocardial perfusion enough to cause detectable ST-
segment changes or clinical angina during exertion.
3. An FNP student is explaining the primary benefit of
HMG-CoA reductase inhibitors (statins) to a patient
with a 12% 10-year ASCVD risk score. Beyond
lowering serum LDL-C, how do statins structurally
stabilize vulnerable atherosclerotic plaques?
A) By thinning the fibrous cap to allow fluid clearance
B) By hardening plaques and calcifying the core to prevent
,rupture
C) By increasing the lipid core volume to absorb
inflammatory cells
D) By dissolving the calcified layers of the arterial wall
Answer: B) By hardening plaques and calcifying the core
to prevent rupture
Rationale: Statins possess pleiotropic effects that
decrease vascular inflammation, reduce the lipid core
size, and increase the thickness and calcification
(hardening) of the fibrous cap, which directly lowers
the risk of plaque rupture and acute myocardial
infarction.
4. When evaluating a comprehensive fasting lipid
panel for a primary prevention patient, which lipid
fraction is directly implicated as the primary
atherogenic vehicle and serves as the primary target
for therapy?
A) High-Density Lipoprotein Cholesterol (HDL-C)
B) Low-Density Lipoprotein Cholesterol (LDL-C)
C) Chylomicrons
D) Very Low-Density Lipoprotein (VLDL)
Answer: B) Low-Density Lipoprotein Cholesterol (LDL-C)
Rationale: LDL-C particles penetrate the damaged
endothelial lining of arteries, undergo oxidation, and
trigger the inflammatory cascade that forms foam
cells and eventual atheromas, making LDL-C the
primary target of lipid-lowering guidelines.
, 5. A 45-year-old female with a history of clinical
ASCVD requires high-intensity statin therapy.
According to the current ACC/AHA guidelines, what is
the expected percentage reduction in serum LDL-C
when a high-intensity statin is used correctly?
A) 15% to <30%
B) 30% to <50%
C) ≥50%
D) <15%
Answer: C) ≥50%
Rationale: High-intensity statin therapy is strictly
defined by its ability to lower baseline serum LDL-C
levels by 50% or greater when taken consistently as
prescribed.
6. Which of the following statin regimens represents a
validated high-intensity lipid-lowering option?
A) Pravastatin 40 mg daily
B) Simvastatin 40 mg daily
C) Atorvastatin 20 mg daily
D) Rosuvastatin 20 mg daily
Answer: D) Rosuvastatin 20 mg daily
Rationale: Only Rosuvastatin 20–40 mg and
Atorvastatin 40–80 mg are clinically classified as high-
intensity statin therapies. Simvastatin 40 mg and
Atorvastatin 20 mg are moderate-intensity.
7. A 52-year-old male with type 2 diabetes mellitus and
an LDL-C of 115 mg/dL is being evaluated. He has no
prior history of ASCVD. According to primary
